NYSE:ASPN
Aspen Aerogels Inc.
Aspen Aerogels Inc.'s revenue fell 40.1% in fiscal 2025 to $271.1M while operating margin fell to −139.5%, its lowest in 10 years. Free cash flow was −$4.6M, −1.7% of revenue, and the diluted share count rose 2.5%.Summary generated from Aspen Aerogels Inc.'s SEC filings. Latest annual report filed Mar 23, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$271.1M
Revenue growth−40.1%
Revenue, 5-yr CAGR+22.0%
Gross margin17.0%
Operating margin−139.5%
Net margin−143.7%
ROIC−94.4%
Return on equity−91.6%
Debt / equity0.28
Free cash flow−$4.6M
FCF margin−1.7%
Share count change+2.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 122 | 180 | 239 | 453 | 271 |
| Operating income | −41 | −79 | −49 | 55 | −378 |
| Net income | −37 | −83 | −46 | 13 | −390 |
| Free cash flow | −32 | −272 | −218 | −41 | −5 |
Recent filings
- 4Insider transaction report
Oct 1, 2026 - 4Insider transaction report
Sep 24, 2026 - 8-KRegulation FD disclosure
Sep 15, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KDirector or officer change
May 18, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 8, 2026 - 8-KResults of operations and financial condition
May 7, 2026